The Female Health Company Schedules Fiscal Year End Conference Call for Monday, November 26, 2007

Monday, November 19, 2007 General News J E 4
CHICAGO, Nov. 19 The Female Health Company(Amex: FHC) today announced that it will host an investor conference call todiscuss its operating results for the quarter and fiscal year endedSeptember 30, 2007. The Company plans to report its quarterly and year-endoperating results on the morning of Monday, November 26, 2007, and an investorconference call has been scheduled for 11:00 a.m. Eastern Time (EST) on thesame day.

Shareholders and other interested parties may participate in theconference call by dialing 888-603-6873 (international participants dial973-582-2706) and referencing the conference ID 9473190, a few minutes before11:00 a.m. EST on November 26, 2007. A replay of the call will be availablethrough December 10, 2007 by dialing 877-519-4471 (international callers dial973-341-3080), and entering the conference ID 9473190.

About The Female Health Company

The Female Health Company, based in Chicago, Illinois, manufactures andmarkets the FC Female Condom(R), which is primarily distributed by publichealth organizations and donor groups in over 90 developing countries aroundthe world. World-wide, the Female Condom is available in various programs in108 countries. The Company owns certain worldwide rights to the FC FemaleCondom(R), including patents that have been issued in the United States,United Kingdom, Japan, France, Italy, Germany, Spain, the European PatentConvention, the People's Republic of China, Canada, South Korea and Australia.FC Female Condom(R) is the only available FDA-approved product controlled by awoman that offers dual protection against sexually transmitted diseases,including HIV/AIDS, and unintended pregnancy.

"Safe Harbor" statement under the Private Securities Litigation Reform Actof 1995: The statements in this release which are not historical in fact areforward-looking statements based upon the Company's current plans andstrategies, and reflect the Company's current assessment of the risks anduncertainties related to its business, including such things as product demandand market acceptance; the economic and business environment and the impact ofgovernment actions; currency risks; capacity; efficiency and supplyconstraints; and other risk detailed in the Company's press releases,shareholder communications and Securities and Exchange Commission filings.Actual events affecting the Company and the impact of such events upon theCompany's operations may vary from those currently anticipated.

For more information about the Female Health Company visit the Company'sweb site at and

To be added to the Company's e-mail alert list, please send an e-mail

SOURCE The Female Health Company


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Free White Paper From The Beryl Institute Quantifi...
Bioponic Phytoceuticals Introduces All Natural Bab...